Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1071 | 1003 | 1295 | 1040 | 1672 | 2847 |
Fund Return | 7.08% | 0.26% | 29.5% | 1.33% | 10.83% | 11.03% |
Place in category | 307 | 150 | 290 | 152 | 84 | 21 |
% in Category | 69 | 33 | 71 | 41 | 24 | 18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TRUS Smaller Companies Equity Fundq | 5.3B | 7.05 | 1.28 | 10.96 | ||
T Rowe Price SICAV USSmallCoEqS USD | 5.3B | 7.81 | 2.21 | - | ||
TRUS Smaller Companies Equity Funda | 5.3B | 6.31 | 0.53 | 10.22 | ||
TRGlobal Focused Growth Equity Funa | 4.01B | 14.75 | -0.47 | 11.69 | ||
TRGlobal Focused Growth Equity Funu | 4.01B | 15.61 | 0.43 | 12.72 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TRUS Smaller Companies Equity Fundq | 5.3B | 7.05 | 1.28 | 10.96 | ||
T Rowe Price SICAV USSmallCoEqS USD | 5.3B | 7.81 | 2.21 | - | ||
TRUS Smaller Companies Equity Funda | 5.3B | 6.31 | 0.53 | 10.22 | ||
LU1864950719 | 1.93B | 9.21 | 1.93 | 9.93 | ||
LU1864951105 | 1.93B | 9.93 | 2.74 | 10.80 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Molina Healthcare | US60855R1005 | 1.49 | 310.30 | -0.51% | |
Teledyne Technologies | US8793601050 | 1.49 | 478.89 | +0.08% | |
Bruker | US1167941087 | 1.34 | 59.50 | +3.39% | |
Renaissancere | BMG7496G1033 | 1.32 | 284.50 | -0.85% | |
Haemonetics | US4050241003 | 1.29 | 83.51 | -2.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review